Compare RAIL & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAIL | SEER |
|---|---|---|
| Founded | 1901 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.0M | 113.0M |
| IPO Year | 2005 | 2020 |
| Metric | RAIL | SEER |
|---|---|---|
| Price | $4.58 | $1.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $10.67 | $4.00 |
| AVG Volume (30 Days) | ★ 303.0K | 147.6K |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 134.94 | 9.40 |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $500,991,000.00 | $16,578,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $48.30 | $20.50 |
| P/E Ratio | $14.15 | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $3.85 | $1.42 |
| 52 Week High | $14.90 | $2.38 |
| Indicator | RAIL | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 21.46 |
| Support Level | $3.94 | N/A |
| Resistance Level | $5.48 | $1.81 |
| Average True Range (ATR) | 0.34 | 0.11 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 42.27 | 10.33 |
FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.